Works matching IS 08876924 AND DT 2008 AND VI 22 AND IP 4

Results: 38

A new case with rare e6a2 BCR–ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment.
Published in:
2008
By:
- Schnittger, S.;
- Bacher, U.;
- Kern, W.;
- Haferlach, T.;
- Hertenstein, B.;
- Haferlach, C.
Publication type:
Letter
Validation of NG2 antigen in identifying BP-ALL patients with MLL rearrangements using qualitative and quantitative flow cytometry: a prospective study.
Published in:
2008
By:
- Zangrando, A.;
- Intini, F.;
- te Kronnie, G.;
- Basso, G.
Publication type:
Letter
Clonal expansion of non-leukemic cells expressing two novel MLL–ELL variants differing in transforming activity.
Published in:
2008
By:
- Takeuchi, M.;
- Nakaseko, C.;
- Miyagi, S.;
- Takeda, Y.;
- Ozawa, S.;
- Ohwada, C.;
- Cho, R.;
- Nishimura, M.;
- Saito, Y.;
- Iwama, A.
Publication type:
Letter
Re: Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients. Alvarez-Larrán A et al.
Published in:
2008
By:
- Westerman, D.;
- Juneja, S.
Publication type:
Letter
Reply to ‘Re: Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients. Alvarez-Larrán A et al.’ by Westerman et al.
Published in:
2008
By:
- Alvarez-Larrán, A.;
- Cervantes, F.;
- Besses, C.
Publication type:
Letter
Erythroid variant of chronic myelogenous leukemia.
Published in:
2008
By:
- Talreja, N.;
- Abdulhaq, H.;
- Shadduck, R. K.;
- Rossetti, J.;
- Jalil, A.;
- Makary, A.;
- Lister, J.
Publication type:
Letter
Reply to ‘Re: Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients. Alvarez-Larrán et al. Leukemia 2007; 21: 1218–1223’.
Published in:
2008
By:
- Westerman, D.;
- Juneja, S.
Publication type:
Letter
Reply to Westerman et al.: ‘Re: Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients. Alvarez-Larrán A et al. Leukemia 2007; 21: 1218–1223’
Published in:
2008
By:
- Alvarez-Larrán, A.;
- Cervantes, F.;
- Besses, C.
Publication type:
Letter
Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients.
Published in:
2008
By:
- Butcher, C. M.;
- Hahn, U.;
- To, L. B.;
- Gecz, J.;
- Wilkins, E. J.;
- Scott, H. S.;
- Bardy, P. G.;
- D'Andrea, R. J.
Publication type:
Letter
Contribution of GM-CSF and IL-8 to the CD44-induced differentiation of acute monoblastic leukemia.
Published in:
2008
By:
- Delaunay, J.;
- Lecomte, N.;
- Bourcier, S.;
- Qi, J.;
- Gadhoum, Z.;
- Durand, L.;
- Chomienne, C.;
- Robert-Lézénès, J.;
- Smadja-Joffe, F.
Publication type:
Letter
Association of 3q21q26 syndrome and late-appearing Philadelphia chromosome in acute myeloid leukemia.
Published in:
2008
By:
- Quintás-Cardama, A.;
- Gibbons, D. L.;
- Cortes, J.;
- Bobadilla, D.;
- Slovak, M. L.;
- Kantarjian, H.;
- Abruzzo, L. V.
Publication type:
Letter
Effect of parental history of cancer on the development of second neoplasms after lymphoma at the same site than the parents.
Published in:
2008
By:
- Lorenzo Bermejo, J.;
- Sundquist, J.;
- Hemminki, K.
Publication type:
Letter
The genetic characterization of acute promyelocytic leukemia with cryptic t(15;17) including a new recurrent additional cytogenetic abnormality i(17)(q10).
Published in:
2008
By:
- Kim, M.;
- Lim, J.;
- Kim, Y.;
- Han, K.;
- Lee, D. H.;
- Chung, N. G.;
- Cho, B.;
- Kim, H. K.;
- Eom, K. S.;
- Min, C.-K.;
- Min, W.-S.
Publication type:
Letter
Proteasome inhibition therapies in childhood cancer.
Published in:
2008
By:
- Zaman, F.;
- Fadeel, B.;
- Sävendahl, L.
Publication type:
Letter
Reply to ‘Proteasome inhibition therapies in childhood cancer’ by Zaman et al.
Published in:
2008
By:
- Terpos, E.;
- Sezer, O.
Publication type:
Letter
The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2<sup>V617F</sup>.
Published in:
Leukemia (08876924), 2008, v. 22, n. 4, p. 740, doi. 10.1038/sj.leu.2405049
By:
- Guerini, V.;
- Barbui, V.;
- Spinelli, O.;
- Salvi, A.;
- Dellacasa, C.;
- Carobbio, A.;
- Introna, M.;
- Barbui, T.;
- Golay, J.;
- Rambaldi, A.
Publication type:
Article
Suppression of abnormal karyotype predicts superior survival in multiple myeloma.
Published in:
2008
By:
- Arzoumanian, V.;
- Hoering, A.;
- Sawyer, J.;
- van Rhee, F.;
- Bailey, C.;
- Gurley, J.;
- Shaughnessy, J. D.;
- Anaissie, E.;
- Crowley, J.;
- Barlogie, B.;
- Shaughnessy, J D Jr
Publication type:
journal article
BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism.
Published in:
Leukemia (08876924), 2008, v. 22, n. 4, p. 791, doi. 10.1038/leu.2008.3
By:
- Liu, J.;
- Joha, S.;
- Idziorek, T.;
- Corm, S.;
- Hetuin, D.;
- Philippe, N.;
- Preudhomme, C.;
- Quesnel, B.
Publication type:
Article
The role of CALM-AF10 gene fusion in acute leukemia.
Published in:
2008
By:
- Caudell, D.;
- Aplan, P. D.
Publication type:
journal article
E2A-ZNF384 and NOL1-E2A fusion created by a cryptic t(12;19)(p13.3; p13.3) in acute leukemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 4, p. 723, doi. 10.1038/sj.leu.2405084
By:
- Zhong, C.-h.;
- Prima, V.;
- Liang, X.;
- Frye, C.;
- McGavran, L.;
- Meltesen, L.;
- Wei, Q.;
- Boomer, T.;
- Varella-Garcia, M.;
- Gump, J.;
- Hunger, S. P.
Publication type:
Article
Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors.
Published in:
2008
By:
- Konig, H.;
- Holtz, M.;
- Modi, H.;
- Manley, P.;
- Holyoake, T. L.;
- Forman, S. J.;
- Bhatia, R.
Publication type:
journal article
Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study.
Published in:
Leukemia (08876924), 2008, v. 22, n. 4, p. 842, doi. 10.1038/sj.leu.2405087
By:
- San-Miguel, J. F.;
- Richardson, P. G.;
- Sonneveld, P.;
- Schuster, M. W.;
- Irwin, D.;
- Stadtmauer, E. A.;
- Facon, T.;
- Harousseau, J.-L.;
- Ben-Yehuda, D.;
- Lonial, S.;
- Goldschmidt, H.;
- Reece, D.;
- Bladé, J.;
- Boccadoro, M.;
- Cavenagh, J. D.;
- Neuwirth, R.;
- Boral, A. L.;
- Esseltine, D.-L.;
- Anderson, K. C.
Publication type:
Article
KSHV-transformed primary effusion lymphoma cells induce a VEGF-dependent angiogenesis and establish functional gap junctions with endothelial cells.
Published in:
Leukemia (08876924), 2008, v. 22, n. 4, p. 826, doi. 10.1038/sj.leu.2405081
By:
- Haddad, L.;
- El Hajj, H.;
- Abou-Merhi, R.;
- Kfoury, Y.;
- Mahieux, R.;
- El-Sabban, M.;
- Bazarbachi, A.
Publication type:
Article
Cooperative genetic defects in TLX3 rearranged pediatric T-ALL.
Published in:
2008
By:
- Van Vlierberghe, P.;
- Homminga, I.;
- Zuurbier, L.;
- Gladdines-Buijs, J.;
- van Wering, E. R.;
- Horstmann, M.;
- Beverloo, H. B.;
- Pieters, R.;
- Meijerink, J. P. P.
Publication type:
journal article
Expression and mutation status of candidate kinases in multiple myeloma.
Published in:
2008
By:
- Claudio, J. O.;
- Zhan, F.;
- Zhuang, L.;
- Khaja, R.;
- Zhu, Y. X.;
- Sivananthan, K.;
- Trudel, S.;
- Masih-Khan, E.;
- Fonseca, R.;
- Bergsagel, P. L.;
- Scherer, S. W.;
- Shaughnessy, J.;
- Stewart, A. K.
Publication type:
Correction Notice
Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway.
Published in:
2008
By:
- Zhang, W.;
- Konopleva, M.;
- Ruvolo, V. R.;
- McQueen, T.;
- Evans, R. L.;
- Bornmann, W. G.;
- McCubrey, J.;
- Cortes, J.;
- Andreeff, M.
Publication type:
journal article
Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C/EBPalpha.
Published in:
2008
By:
- Bararia, D.;
- Trivedi, A. K.;
- Zada, A. A. Peer;
- Greif, P. A.;
- Mulaw, M. A.;
- Christopeit, M.;
- Hiddemann, W.;
- Bohlander, S. K.;
- Behre, G.
Publication type:
journal article
High titer autoantibodies to GM-CSF in patients with AML, CML and MDS are associated with active disease.
Published in:
2008
By:
- Sergeeva, A.;
- Ono, Y.;
- Rios, R.;
- Molldrem, J. J.
Publication type:
journal article
MDM2 antagonist nutlin-3 is a potent inducer of apoptosis in pediatric acute lymphoblastic leukemia cells with wild-type p53 and overexpression of MDM2.
Published in:
2008
By:
- Gu, L.;
- Zhu, N.;
- Findley, H. W.;
- Zhou, M.
Publication type:
journal article
Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival.
Published in:
Leukemia (08876924), 2008, v. 22, n. 4, p. 756, doi. 10.1038/sj.leu.2405097
By:
- Tefferi, A.;
- Lasho, T. L.;
- Huang, J.;
- Finke, C.;
- Mesa, R. A.;
- Li, C. Y.;
- Wu, W.;
- Hanson, C. A.;
- Pardanani, A.
Publication type:
Article
Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype.
Published in:
Leukemia (08876924), 2008, v. 22, n. 4, p. 835, doi. 10.1038/leu.2008.12
By:
- Ehlers, A.;
- Oker, E.;
- Bentink, S.;
- Lenze, D.;
- Stein, H.;
- Hummel, M.
Publication type:
Article
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 4, p. 771, doi. 10.1038/leu.2008.5
By:
- Flohr, T.;
- Schrauder, A.;
- Cazzaniga, G.;
- Panzer-Grümayer, R.;
- van der Velden, V.;
- Fischer, S.;
- Stanulla, M.;
- Basso, G.;
- Niggli, F. K.;
- Schäfer, B. W.;
- Sutton, R.;
- Koehler, R.;
- Zimmermann, M.;
- Valsecchi, M. G.;
- Gadner, H.;
- Masera, G.;
- Schrappe, M.;
- van Dongen, J. J. M.;
- Biondi, A.;
- Bartram, C. R.
Publication type:
Article
C/EBPalpha, do not forget your TIP60.
Published in:
2008
By:
- C. W. E. So;
- van der Reijden, B. A.;
- So, C W E
Publication type:
Editorial
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy.
Published in:
Leukemia (08876924), 2008, v. 22, n. 4, p. 708, doi. 10.1038/leu.2008.27
By:
- McCubrey, J. A.;
- Steelman, L. S.;
- Abrams, S. L.;
- Bertrand, F. E.;
- Ludwig, D. E.;
- Bäsecke, J.;
- Libra, M.;
- Stivala, F.;
- Milella, M.;
- Tafuri, A.;
- Lunghi, P.;
- Bonati, A.;
- Martelli, A. M.
Publication type:
Article
A kinder, gentler way: control of the proliferative tumor compartment, not cosmetic complete response, should be the goal of myeloma therapy.
Published in:
2008
By:
- Bergsagel, P. L.
Publication type:
Editorial
Sequencing of subcloned PCR products facilitates earlier detection of BCR-ABL1<sup>T315I</sup> and other mutants compared to direct sequencing of the ABL1 kinase domain.
Published in:
2008
By:
- Quintás-Cardama, A.;
- Gibbons, D. L.;
- Kantarjian, H.;
- Talpaz, M.;
- Donato, N.;
- Cortes, J.
Publication type:
Letter
Downregulation of Mcl-1 potentiates HDACi-mediated apoptosis in leukemic cells.
Published in:
2008
By:
- Inoue, S.;
- Walewska, R.;
- Dyer, M. J. S.;
- Cohen, G. M.
Publication type:
journal article
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.
Published in:
2008
By:
- Steelman, L. S.;
- Abrams, S. L.;
- Whelan, J.;
- Bertrand, F. E.;
- Ludwig, D. E.;
- Bäsecke, J.;
- Libra, M.;
- Stivala, F.;
- Milella, M.;
- Tafuri, A.;
- Lunghi, P.;
- Bonati, A.;
- Martelli, A. M.;
- McCubrey, J. A.;
- Bäsecke, J
Publication type:
journal article